Banner Image
About the Loesgen Lab

The Loesgen Lab uses a variety of state-of-the-art techniques to identify and develop drug leads from the metabolic products of microbial organisms, with a special emphasis on endophytic fungi and rare actinomycetes. Our research program currently focuses on the discovery of new anticancer, antimicrobial, and antiviral compounds from microbial sources.

Our multidisciplinary approach to biomedical research brings together students and researchers from diverse backgrounds, including pharmaceutical sciences, chemistry, biochemistry, molecular biology, and microbiology.

Group photo
April 2018
Our joint paper with the Weis lab has been published. Congrats Paige and Donovon.
March 2018
Sandra gives a seminar at the Marine Natural Product Gordon Conference
March 2018
Mahsa joins the Loesgen lab. Welcome Mahsa
March 2018
Loesgen Lab presents at the 2018 Volcano Conference and the Oregon Academy of Science meeting.
January 2018
UG Jason joins the lab with an URSA ENGAGE Stipend. UG Anabel joins the lab as OSU STEM scholar. Welcome!
January 2018
Mensacarcin in the news: OPB
October 2017
Mensacarcin is published in JBC. Congrats Birte and Elizabeth.
August 2017
ASP meeting ended after a successful week in Portland. Great job hosting the meeting, Loesgen Lab.
May 2017
Sandra Loesgen gives a seminar at the Goethe University in Frankfurt
March 2017
Sandra Loesgen gives an invited seminar at the 3rd Natural Products Fusion-Conference, Cancun Mexico.
February 2017
UG Molly Austin receives an URSA ENGAGE award and joins the Loesgen Lab. Welcome!
February 2017
Zoe Zhu and Donovon Adpressa present talks at the 2017 Volcano Conference. Paige Mandelare, Ross Overacker, George Neuhaus, and Zach Konkel present a poster.